Cegrogen Biotech is a leading innovator in cell culture, offering a comprehensive suite of services for the development and optimization of CHO cell lines. Since 2019, our dedicated team, led by the industry expert Peter Hofreiter, has been instrumental in helping clients unlock the full potential of their therapeutic protein production platforms.
CHO (Chinese Hamster Ovary) cells are the workhorses of the biopharmaceutical industry, responsible for the manufacturing of therapeutic proteins. At Cegrogen Biotech, we understand the complexities of CHO cell line development and possess the expertise to guide you through every step of the process.
Our team has extensive experience in:
Cegrogen Biotech prioritizes providing independent advice throughout the CHO cell line development process. Our team's unbiased evaluations of media and processes ensure you receive the most suitable solutions for your specific needs. We understand the importance of collaboration and strive to work seamlessly with your process development and upstream process partners for a successful outcome.
By partnering with Cegrogen Biotech for your CHO cell line development needs, you can expect:
At Cegrogen Biotech, we are committed to being your trusted partner in unlocking the full potential of your CHO cell lines. Contact us today to discuss your specific needs and learn how we can help you achieve your biopharmaceutical development goals.